A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce

Abstract Regular PCR testing of nasopharyngeal swabs from symptomatic individuals for SARS-CoV-2 virus has become the established method by which health services are managing the COVID-19 pandemic. Businesses such as AstraZeneca have also prioritised voluntary asymptomatic testing to keep workplaces...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Nikki Carter, Maryam Clausen, Rebecca A. Halpin, Colin Blackmore, Kang Cai, Oona Delpuech, Alexander Kohlmann, Otto Magnusson, Ruth March, Daniel O’Neill, Kasthuri Prakash, James Sherwood, Tabetha Sundin, Jason Swift, Azar Tarakameh, Marilou Wijdicks, Daniel Wise, Mark Fidock
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/cd949d71d09d40a391ffbdef580d8d56
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:cd949d71d09d40a391ffbdef580d8d56
record_format	dspace
spelling	oai:doaj.org-article:cd949d71d09d40a391ffbdef580d8d562021-12-02T17:41:28ZA novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce10.1038/s41598-021-92070-w2045-2322https://doaj.org/article/cd949d71d09d40a391ffbdef580d8d562021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-92070-whttps://doaj.org/toc/2045-2322Abstract Regular PCR testing of nasopharyngeal swabs from symptomatic individuals for SARS-CoV-2 virus has become the established method by which health services are managing the COVID-19 pandemic. Businesses such as AstraZeneca have also prioritised voluntary asymptomatic testing to keep workplaces safe and maintain supply of essential medicines to patients. We describe the development of an internal automated SARS-CoV-2 testing programme including the transformative introduction of saliva as an alternative sample type.Nikki CarterMaryam ClausenRebecca A. HalpinColin BlackmoreKang CaiOona DelpuechAlexander KohlmannOtto MagnussonRuth MarchDaniel O’NeillKasthuri PrakashJames SherwoodTabetha SundinJason SwiftAzar TarakamehMarilou WijdicksDaniel WiseMark FidockNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Nikki Carter Maryam Clausen Rebecca A. Halpin Colin Blackmore Kang Cai Oona Delpuech Alexander Kohlmann Otto Magnusson Ruth March Daniel O’Neill Kasthuri Prakash James Sherwood Tabetha Sundin Jason Swift Azar Tarakameh Marilou Wijdicks Daniel Wise Mark Fidock A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce
description	Abstract Regular PCR testing of nasopharyngeal swabs from symptomatic individuals for SARS-CoV-2 virus has become the established method by which health services are managing the COVID-19 pandemic. Businesses such as AstraZeneca have also prioritised voluntary asymptomatic testing to keep workplaces safe and maintain supply of essential medicines to patients. We describe the development of an internal automated SARS-CoV-2 testing programme including the transformative introduction of saliva as an alternative sample type.
format	article
author	Nikki Carter Maryam Clausen Rebecca A. Halpin Colin Blackmore Kang Cai Oona Delpuech Alexander Kohlmann Otto Magnusson Ruth March Daniel O’Neill Kasthuri Prakash James Sherwood Tabetha Sundin Jason Swift Azar Tarakameh Marilou Wijdicks Daniel Wise Mark Fidock
author_facet	Nikki Carter Maryam Clausen Rebecca A. Halpin Colin Blackmore Kang Cai Oona Delpuech Alexander Kohlmann Otto Magnusson Ruth March Daniel O’Neill Kasthuri Prakash James Sherwood Tabetha Sundin Jason Swift Azar Tarakameh Marilou Wijdicks Daniel Wise Mark Fidock
author_sort	Nikki Carter
title	A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce
title_short	A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce
title_full	A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce
title_fullStr	A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce
title_full_unstemmed	A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce
title_sort	novel automated sars-cov-2 saliva pcr test protects a global asymptomatic workforce
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/cd949d71d09d40a391ffbdef580d8d56
work_keys_str_mv	AT nikkicarter anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT maryamclausen anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT rebeccaahalpin anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT colinblackmore anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT kangcai anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT oonadelpuech anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT alexanderkohlmann anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT ottomagnusson anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT ruthmarch anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT danieloneill anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT kasthuriprakash anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT jamessherwood anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT tabethasundin anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT jasonswift anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT azartarakameh anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT marilouwijdicks anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT danielwise anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT markfidock anovelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT nikkicarter novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT maryamclausen novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT rebeccaahalpin novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT colinblackmore novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT kangcai novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT oonadelpuech novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT alexanderkohlmann novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT ottomagnusson novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT ruthmarch novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT danieloneill novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT kasthuriprakash novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT jamessherwood novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT tabethasundin novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT jasonswift novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT azartarakameh novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT marilouwijdicks novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT danielwise novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce AT markfidock novelautomatedsarscov2salivapcrtestprotectsaglobalasymptomaticworkforce
_version_	1718379670054895616

A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce

Ejemplares similares